A multi-center trial on efficacy and safety of the LifeTech CeraFlex(TM) ASD occluder for transcatheter closure in patients with secundum atrial septal defects

BACKGROUND: The last decades have brought remarkable improvements in treatment strategy and occluder modification of secundum atrial septal defect (ASD) closure. Approval, efficacy and safety of ASD closure devices have previously been demonstrated. This study investigated the clinical efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritz, Celina, Engelhardt, Andrea, Grohmann, Jochen, Dähnert, Ingo, Hummel, Johanna, Tanase, Daniel, Ewert, Peter, Eicken, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412214/
https://www.ncbi.nlm.nih.gov/pubmed/36033225
http://dx.doi.org/10.21037/cdt-21-798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412214/
https://www.ncbi.nlm.nih.gov/pubmed/36033225
http://dx.doi.org/10.21037/cdt-21-798

Ejemplares similares